Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | -4.12% | -8.50% | +14.28% |
04-01 | HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-01 | HCW Biologics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 52.95M 4.22B |
---|---|---|---|---|---|
Net income 2024 * | -23M -1.83B | Net income 2025 * | -29M -2.31B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.46
x | P/E ratio 2025 * |
-2.55
x | Employees | 45 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.07% |
1 day | -4.12% | ||
1 week | -8.50% | ||
Current month | -20.01% | ||
1 month | -20.01% | ||
3 months | +27.26% | ||
6 months | -12.51% | ||
Current year | +14.28% |
Managers | Title | Age | Since |
---|---|---|---|
Hing Wong
FOU | Founder | 70 | 01/04/18 |
Rebecca Byam
DFI | Director of Finance/CFO | 68 | 30/09/19 |
Peter Rhode
CTO | Chief Tech/Sci/R&D Officer | 66 | 30/04/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Garrett
CHM | Chairman | 73 | 30/04/21 |
Hing Wong
FOU | Founder | 70 | 01/04/18 |
Rick Greene
BRD | Director/Board Member | 59 | 30/04/21 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.4 | -4.12% | 2,444 |
25/04/24 | 1.46 | -2.67% | 2,755 |
24/04/24 | 1.5 | -6.46% | 888 |
23/04/24 | 1.604 | -1.62% | 8,757 |
22/04/24 | 1.63 | +6.54% | 3,309 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.28% | 52.95M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- HCWB Stock